Institute for Cancer Research

Kjetil Taskén
Instiute head

Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded. Read more

Annual report 2019 (pdf):
Abstract (in Norwegian)
Download in single page format - double page (broad) format

Publication overview

Current news and events

Industry development agreement for innovative eye syringe

Morten C. Moe (left) and Jan Teje Andersen
Morten C. Moe (left) and Jan Teje Andersen

The Department of Ophthalmology at Oslo University Hospital and the Laboratory of Adaptive Immunity and Homeostasis of both Oslo University Hospital and University of Oslo, have entered an industry development agreement with the Dutch medical device company SJJ Solutions. The collaboration has resulted in a prototype of a tailor-made syringe optimised for eye injections.

The UiO's Innovation Prize for 2020 awarded to Bjarne Bogen

Bjarne Bogen
Bjarne Bogen

A unanimous prize committee highlights Bogen’s contributions to medical vaccine research as critical to the field of medicine and research-based innovation at the University of Oslo. Bjarne Bogen is head of the Cellular and Molecular Immunology research group at the Department of Immunology, under the Division of Laboratory Medicine. He is a professor at the Institute of Clinical Medicine and previously headed the K.G. Jebsen Centre for Influenza Vaccine Research, which closed in 2019. The award was distributed on September 2nd during the University of Oslo’s Annual Celebration.

Substantial support from the Pink Ribbon campaign to cancer research

From the ceremony
From the ceremony

An enormous pink commitment from Norwegians last year means that six breast cancer researchers now receive a total of NOK 25 million. Among these are the following three scientist from Oslo University Hospital: Jon Amund Kyte (Department of Cancer Immunology), Therese Sørlie (Department of Cancer Genetics) and Xavier Tekpli (Department of Medical Genetics).

The goal of the Pink Ribbon campaign is to show solidarity with those affected by breast cancer, increase knowledge about the disease and provide support for research. Since 1999, Norwegians have contributed more than NOK 280 million.

Units and subpages

View all subunitsHide all subunits